Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant TIMELESS antibody (Alexa Fluor 647)

The Rabbit Monoclonal anti-TIMELESS antibody has been validated for WB, IHC, IF and ICC. It is suitable to detect TIMELESS in samples from Human.
Catalog No. ABIN7774165

Quick Overview for Recombinant TIMELESS antibody (Alexa Fluor 647) (ABIN7774165)

Target

See all TIMELESS Antibodies
TIMELESS (Timeless Homolog (TIMELESS))

Antibody Type

Recombinant Antibody

Reactivity

  • 41
  • 15
  • 12
  • 9
  • 7
  • 6
  • 5
  • 5
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 41
  • 3
  • 1
Rabbit

Clonality

  • 34
  • 11
Monoclonal

Conjugate

  • 30
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TIMELESS antibody is conjugated to Alexa Fluor 647

Application

  • 37
  • 17
  • 15
  • 15
  • 11
  • 9
  • 4
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
  • Purpose

    Conjugated Timeless Rabbit mAb

    Specificity

    Timeless Antibody detects endogenous levels of total Timeless

    Purification

    Affinity-chromatography

    Immunogen

    A synthesized peptide derived from human Timeless
  • Application Notes

    most applications: 1: 50 - 1: 250

    Restrictions

    For Research Use only
  • Buffer

    Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light!

    Storage

    4 °C

    Storage Comment

    Store at 4°C in dark for 6 months
  • Target

    TIMELESS (Timeless Homolog (TIMELESS))

    Alternative Name

    Timeless

    Background

    HTIM, TIM, TIM1, Timeless, timeless circadian clock 1, TIMELESS1,

    Molecular Weight

    150kDa

    UniProt

    Q9UNS1

    Pathways

    Protein targeting to Nucleus, Photoperiodism
You are here:
Chat with us!